Updating results

87 results for dyspepsia Sort: Relevance | Date

Dyspepsia and gastro-oesophageal reflux disease

Everything NICE has said on investigating and managing dyspepsia and gastro-oesophageal reflux disease in an interactive flowchart

NICE Pathway Published September 2014 Last updated October 2017

Suspected cancer recognition and referral

Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart

NICE Pathway Published June 2015 Last updated September 2017

Dyspepsia: Management of dyspepsia in adults in primary care (CG17)

This guidance has been updated and replaced by gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management

Clinical guideline Published August 2004 Withdrawn

Idiopathic pulmonary fibrosis in adults: diagnosis and management (CG163)

Evidence-based recommendations on diagnosing and managing idiopathic pulmonary fibrosis (IPF) (hardening of the lungs) in adults

Clinical guideline Published June 2013 Last updated May 2017

The clinical and cost effectiveness of proton pump inhibitors for the treatment of dyspepsia (TA7)

This guidance has been updated and replaced by gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management

Technology appraisal guidance Published July 2000 Withdrawn

Non-Hodgkin’s lymphoma: diagnosis and management (NG52)

Evidence-based recommendations on diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years and over

NICE guideline Published July 2016

Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation (TA249)

Evidence-based recommendations on dabigatran etexilate (Pradaxa) for preventing stroke and systemic embolism in atrial fibrillation (AF)

Technology appraisal guidance Published March 2012

Barrett's oesophagus: ablative therapy (CG106)

Evidence-based recommendations on care and treatment of adults having ablative therapy to treat Barrett’s oesophagus with high-grade dysplasia…

Clinical guideline Published August 2010

Catheterless oesophageal pH monitoring (IPG187)

Evidence-based recommendations on catheterless oesophageal pH monitoring (placing small wireless capsule in gullet to check the level of acid)

Interventional procedures guidance Published July 2006

Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease (IPG222)

Evidence-based recommendations on endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for gastro-oesophageal reflux

Interventional procedures guidance Published June 2007

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (CG68)

Evidence-based recommendations on the diagnosis and initial management of stroke and transient ischaemic attack (TIA or ‘mini-stroke’) in over 16s

Clinical guideline Published July 2008 Last updated March 2017

ESUOM13: Gastroparesis in adults: oral erythromycin

Summary of the evidence on oral erythromycin for gastroparesis (delayed stomach emptying) in adults to inform local NHS planning and decision-making

Evidence summary Published June 2013

ESUOM18: Promoting tolerance of enteral feeds in children and young people: domperidone

Summary of the evidence on domperidone to promote tolerance of enteral feeds in children and young people..

Evidence summary Published July 2013 Last updated September 2014

ESUOM22: Bile acid malabsorption: colesevelam

Summary of the evidence on colesevelam for treating bile acid malabsorption (BAM) to inform local NHS planning and decision-making

Evidence summary Published October 2013

Other specialist management:- What specialist management is effective for people whose symptoms do not respond to PPIs despite optimum primary care, or for people whose symptoms return after surgery?

reflux disease and dyspepsia in adults: investigation and management Number CG184 Date issued September 2014 Other details

Research recommendation Published June 2015

Laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease (IPG585)

Evidence-based recommendations on laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease (GORD) in adults

Interventional procedures guidance Published July 2017

MIB31: Peptest for diagnosing gastro‑oesophageal reflux

Advice on the use of the Peptest for diagnosing gastro-oesophageal reflux disease (GORD) to aid local decision-making

Medtech innovation briefing Published May 2015

ESUOM12: Generalised anxiety disorder: quetiapine

Summary of the evidence on quetiapine monotherapy for treating generalised anxiety disorder (GAD) to inform local NHS planning and decision-making

Evidence summary Published May 2013

Gastrointestinal conditions

Everything NICE has said on gastrointestinal conditions in an interactive flowchart

NICE Pathway Published November 2013 Last updated August 2017

Head and neck cancer (QS146)

Evidence-based statements to deliver quality improvements in assessing, diagnosing and managing head and neck cancer in young people and adults

Quality standard Published March 2017

Shared learning awards previous winners and finalists

The way to medicines optimisation is through the stomach - tackling high prescribing levels using the NICE Dyspepsia guideline to...

Published March 2017

Past appeals and decisions

Dyspepsia - proton pump inhibitors 29 June 2000 TA059 Electroconvulsive Therapy (ECT) 12 February 2003 TA076 Epilepsy (adults) - newer

Published May 2017

Standards and Indicators

: diagnosis and management Complete Drug misuse prevention In progress Public health Drug use disorders Complete Dyspepsia and...

Published March 2016

ESUOM42: Digital ulcers: sildenafil

Summary of the evidence on sildenafil for managing digital ulcers to inform local NHS planning and decision-making

Evidence summary Published March 2015

Cerebral palsy in under 25s: assessment and management (NG62)

Evidence-based recommendations on diagnosing, assessing and managing cerebral palsy in children and young people under 25

NICE guideline Published January 2017

Osteoporosis (QS149)

Evidence-based statements to deliver quality improvements in managing osteoporosis in adults, including assessing risk and preventing fragility fractures

Quality standard Published April 2017

MIB104: NaviCam for diagnosing gastrointestinal tract conditions

Advice on the use of NaviCam for diagnosing gastrointestinal (GI) tract and small bowel conditions to aid local decision-making

Medtech innovation briefing Published May 2017

Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (TA256)

Evidence-based recommendations on rivaroxaban (Xarelto) for preventing stroke and systemic embolism in atrial fibrillation (AF)

Technology appraisal guidance Published May 2012

Heavy menstrual bleeding: assessment and management (CG44)

Evidence-based recommendations on heavy menstrual bleeding (HMB)

Clinical guideline Published January 2007 Last updated August 2016

Irritable bowel syndrome in adults: diagnosis and management (CG61)

Evidence-based recommendations on diagnosing and managing irritable bowel syndrome (IBS) in adults

Clinical guideline Published February 2008 Last updated April 2017

Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (TA161)

Evidence-based recommendations on alendronate, risedronate, raloxifene, strontium ranelate and teriparatide for secondary prevention of osteoporotic fractures

Technology appraisal guidance Published October 2008 Last updated August 2017

Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (TA160)

Evidence-based recommendations on alendronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fractures

Technology appraisal guidance Published October 2008 Last updated August 2017

ESUOM19: Schizophrenia: omega-3 fatty acid medicines

Summary of the evidence on omega-3 fatty acid medicines for treating schizophrenia to inform local NHS planning and decision-making

Evidence summary Published September 2013

ESNM69: Prevention of chemotherapy induced nausea and vomiting in adults: netupitant/palonosetron

Summary of the evidence on netupitant/palonosetron to prevent chemotherapy induced nausea and vomiting to inform local NHS planning and decision-making

Evidence summary Published March 2016

ESUOM23: Transient ischaemic attack: clopidogrel

Summary of the evidence on clopidogrel for treating transient ischaemic attack (TIA) to inform local NHS planning and decision-making

Evidence summary Published December 2013